Offices

Oxford

Park Gate 25 Milton Park
Oxford, OX14 4SH United Kingdom  Map
+44 (0)20 7645 2400 (t)
+44 (0)20 7645 2424 (f)

The Oxford office opened in July 2000 to serve the technology and life sciences community in Oxford and the surrounding Thames Valley area. Our practice here reflects the firm's long-standing focus on technology and life sciences companies, many of which are venture capital-backed companies or are seeking venture capital financing.

Our Oxford lawyers work closely with their colleagues in London, as well as with lawyers in our other offices. The office is part of an integrated European practice of over 100 lawyers.

Oxford and London boast a premier team of UK-qualified lawyers, together with lawyers qualified in the United States and in many of the major European jurisdictions. We are leaders in public and private financings of technology and biotechnology companies and, in particular, in structuring investments by pharmaceutical companies in biotechnology companies. Our capabilities span the full range of corporate transactions from a company’s first term sheet for early-stage financings to public offerings and private M&A. Our experienced corporate lawyers also advise on the full range of legal issues that confront companies and shareholders daily in operating complex international businesses.

Our lawyers are recognised as market leaders in:

  • Corporate
  • Antitrust and Competition
  • Labour and Employment
  • Intellectual Property
  • Executive Compensation and Employee Benefits
  • Technology Transactions and Licensing
Pillman, Joe C.

Joe C. Pillman

Partner

+44 (0)20 7645 2525 (t)

joe.pillman@wilmerhale.com

Publications & News

View

April 17, 2013

Selected 2013 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise‑critical patent litigation; and navigated regulatory issues vital to their success.

April 17, 2013

Selected 2013 Strategic Alliances, Joint Venture and Licensing Transactions

In 2013, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

April 17, 2013

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

March 29, 2013

Senegal and First Step: Infrastructure to Support Critical Agricultural Supply Chains

The Minister of Economy and Finance, Amadou Kane, acting on behalf of the Government of Senegal signed a Letter of Intent (LOI) yesterday with First Step Economic Opportunity Zone Inc. (First Step) to commence planning and fundraising for the development of a special economic zone in the Casamance region of Senegal.

February 20, 2013

Selected 2013 M&A Transactions

In 2012, we advised clients throughout the United States and Europe on more than 100 M&A transactions with an aggregate value of approximately $15 billion, providing guidance in areas including corporate, securities, antitrust and tax.

November 5, 2012

Chambers Recognizes Top WilmerHale UK Lawyers and Practices

September 12, 2012

WilmerHale Earns Spot on 2012 InformationWeek 500 List of Top Technology Innovators Across America

July 16, 2012

WilmerHale Moves to State-of-the-Art, LEED-Certified Offices at 7 World Trade Center

June 6, 2012

Selected 2012 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise‑critical patent litigation; and navigated regulatory issues vital to their success.

June 6, 2012

Selected 2012 Strategic Alliances, Joint Venture and Licensing Transactions

In 2012, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

  • Chambers & Partners - Firm is consistently and prominently ranked in Chambers' guidebooks to the legal profession, which includes significant accolades in the Asia, Europe, Global, USA and UK editions.
  • The European/UK Legal 500 - Firm is frequently ranked in this series of referral guides focusing on each of the Asia Pacific, UK, Europe, Middle East, Africa and US markets.